Group One Trading’s MediciNova MNOV Stock Holding History

Group One Trading’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100	Closed	-$145	–	7193
2024 Q1	$145	Hold	100	–	–	﹤0.01%	6834
2023 Q4	$150	Buy	+100	New	+$181	﹤0.01%	7178
2021 Q2	–	Sell	-3,200	Closed	-$16K	–	8396
2021 Q1	$16K	Buy	+3,200	New	+$18.6K	﹤0.01%	6857
2018 Q1	–	Sell	-2,000	Closed	-$1.29M	–	5120
2017 Q4	$1.29M	Buy	+2,000	New	+$13.3K	0.01%	1511
2016 Q4	–	Sell	-1,000	Closed	-$7K	–	4670
2016 Q3	$7K	Buy	+1,000	New	+$6.74K	﹤0.01%	4143

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Group One Trading's MNOV Position: Q1 2025 in Review

Group One Trading sold out of MediciNova (MNOV) in Q1 2025, closing a stake of 1,400 shares — an estimated $2.48K sold.

Group One Trading first reported a position in MNOV in Q3 2016 and held it in 5 quarters. The position peaked at $41K in Q2 2021. 28 funds tracked by Wall St. Rank hold MNOV as of Q1 2025.

Group One Trading reported no remaining MediciNova position as of Q1 2025 after selling out during the quarter.
Group One Trading sold 1,400 MediciNova shares in Q1 2025, an estimated $2.48K.
Group One Trading first reported a position in MediciNova in Q3 2016 and held it in 5 quarters.
Group One Trading's MediciNova position peaked at $41K in Q2 2021.
28 funds tracked by Wall St. Rank held MediciNova as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.